Published in Autism Res Treat on May 31, 2012
Chromosomal microarray analysis of consecutive individuals with autism spectrum disorders or learning disability presenting for genetic services. Gene (2013) 1.09
High-resolution chromosome ideogram representation of currently recognized genes for autism spectrum disorders. Int J Mol Sci (2015) 0.81
Clinical Presentation and Microarray Analysis of Peruvian Children with Atypical Development and/or Aberrant Behavior. Genet Res Int (2014) 0.77
A Review of the Safety, Efficacy and Mechanisms of Delivery of Nasal Oxytocin in Children: Therapeutic Potential for Autism and Prader-Willi Syndrome, and Recommendations for Future Research. Paediatr Drugs (2017) 0.75
The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism. J Autism Dev Disord (2000) 37.47
Strong association of de novo copy number mutations with autism. Science (2007) 27.84
Mitochondrial diseases in man and mouse. Science (1999) 11.67
Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature (2009) 9.47
Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35
Mitochondrial respiratory-chain diseases. N Engl J Med (2003) 8.68
Identification and evaluation of children with autism spectrum disorders. Pediatrics (2007) 7.54
Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature (2009) 7.39
Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. MMWR Surveill Summ (2009) 7.02
Validation of a brief quantitative measure of autistic traits: comparison of the social responsiveness scale with the autism diagnostic interview-revised. J Autism Dev Disord (2003) 6.51
Pervasive developmental disorders in preschool children. JAMA (2001) 5.13
A case-control family history study of autism. J Child Psychol Psychiatry (1994) 4.66
Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. J Med Genet (2005) 4.14
Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatric disorders. J Med Genet (2008) 3.87
Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry (2005) 3.36
Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry (2009) 3.32
Cerebral lobes in autism: early hyperplasia and abnormal age effects. Neuroimage (2002) 3.28
Cytogenetic and molecular characterization of A2BP1/FOX1 as a candidate gene for autism. Am J Med Genet B Neuropsychiatr Genet (2007) 3.11
The de novo chromosome 16 translocations of two patients with abnormal phenotypes (mental retardation and epilepsy) disrupt the A2BP1 gene. J Hum Genet (2004) 2.89
Clinical genetic testing for patients with autism spectrum disorders. Pediatrics (2010) 2.87
The UCLA-University of Utah epidemiologic survey of autism: recurrence risk estimates and genetic counseling. Am J Psychiatry (1989) 2.85
A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry (2009) 2.69
Microcephaly and macrocephaly in autism. J Autism Dev Disord (1999) 2.54
A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia. Arch Gen Psychiatry (1999) 2.44
Behavioral and emotional problems in young people with pervasive developmental disorders: relative prevalence, effects of subject characteristics, and empirical classification. J Autism Dev Disord (2006) 2.38
Autism spectrum disorders--a genetics review. Genet Med (2011) 2.29
Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. J Med Genet (2009) 2.27
Macrocephaly in children and adults with autism. J Am Acad Child Adolesc Psychiatry (1997) 2.26
Autism and maternally derived aberrations of chromosome 15q. Am J Med Genet (1998) 2.16
Clinical genetics evaluation in identifying the etiology of autism spectrum disorders. Genet Med (2008) 2.04
A double-blind, placebo-controlled study of fluvoxamine in adults with autistic disorder. Arch Gen Psychiatry (1996) 2.04
Neuronal degeneration and mitochondrial dysfunction. J Clin Invest (2003) 2.00
Value of a clinical morphology examination in autism. Am J Med Genet (2000) 1.94
Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet (2011) 1.94
Head circumference is an independent clinical finding associated with autism. Am J Med Genet (2000) 1.94
The comorbidity of Pervasive Developmental Disorder and Attention Deficit Hyperactivity Disorder: results of a retrospective chart review. J Autism Dev Disord (2004) 1.84
Mitochondrial disease in autism spectrum disorder patients: a cohort analysis. PLoS One (2008) 1.68
Pneumonia hospitalizations among young children before and after introduction of pneumococcal conjugate vaccine--United States, 1997-2006. MMWR Morb Mortal Wkly Rep (2009) 1.54
Case series: use of ziprasidone for maladaptive symptoms in youths with autism. J Am Acad Child Adolesc Psychiatry (2002) 1.53
Functional organization of mammalian mitochondrial DNA in nucleoids: history, recent developments, and future challenges. IUBMB Life (2010) 1.52
Mitochondrial DNA abnormalities and autistic spectrum disorders. J Pediatr (2004) 1.49
Efficacy of methylphenidate among children with autism and symptoms of attention-deficit hyperactivity disorder. J Autism Dev Disord (2000) 1.40
A pilot study of D-cycloserine in subjects with autistic disorder. Am J Psychiatry (2004) 1.40
A systematic review and meta-analysis of the fMRI investigation of autism spectrum disorders. Neurosci Biobehav Rev (2011) 1.38
Inverse correlation between frontal lobe and cerebellum sizes in children with autism. Brain (2000) 1.36
Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J Assoc Acad Minor Phys (1998) 1.36
Update on autism: a review of 1300 reports published in 2008. Epilepsy Behav (2009) 1.30
Autism and metabolic diseases. J Child Neurol (2007) 1.26
Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. J Am Acad Child Adolesc Psychiatry (2006) 1.24
Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med (2006) 1.24
Double-blind, placebo-controlled study of amantadine hydrochloride in the treatment of children with autistic disorder. J Am Acad Child Adolesc Psychiatry (2001) 1.19
A retrospective study of memantine in children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl) (2006) 1.18
Genetic testing in autism: how much is enough? Genet Med (2007) 1.16
Trends in primary care antidepressant prescribing 1995-2007: a longitudinal population database analysis. Br J Gen Pract (2011) 1.13
A double-blind comparison of clomipramine, desipramine, and placebo in the treatment of autistic disorder. Arch Gen Psychiatry (1993) 1.13
Fluoxetine treatment of children and adults with autistic disorder and mental retardation. J Am Acad Child Adolesc Psychiatry (1992) 1.11
Brief report: High frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene. J Autism Dev Disord (2006) 1.09
Clonidine treatment of hyperactive and impulsive children with autistic disorder. J Clin Psychopharmacol (1992) 1.09
Ziprasidone in adolescents with autism: an open-label pilot study. J Child Adolesc Psychopharmacol (2007) 1.07
Comparative analysis of neurological disorders focuses genome-wide search for autism genes. Genomics (2008) 1.06
Brief report: non-random X chromosome inactivation in females with autism. J Autism Dev Disord (2005) 1.04
A prospective, open-label trial of memantine in the treatment of cognitive, behavioral, and memory dysfunction in pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 1.03
Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 1.02
Lamotrigine therapy for autistic disorder: a randomized, double-blind, placebo-controlled trial. J Autism Dev Disord (2001) 0.99
Microdeletion syndrome 16p11.2-p12.2: clinical and molecular characterization. Am J Med Genet A (2009) 0.95
Links between genetics and pathophysiology in the autism spectrum disorders. EMBO Mol Med (2011) 0.95
A prospective open trial of guanfacine in children with pervasive developmental disorders. J Child Adolesc Psychopharmacol (2006) 0.94
A crossover study of risperidone in children, adolescents and adults with mental retardation. J Autism Dev Disord (2006) 0.93
Syndromic autism: causes and pathogenetic pathways. World J Pediatr (2009) 0.93
Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry (1996) 0.92
Autism in DSM-5. Am J Psychiatry (2011) 0.91
Functional and structural MR imaging in neuropsychiatric disorders, part 2: application in schizophrenia and autism. AJNR Am J Neuroradiol (2011) 0.89
Naltrexone in autistic children: behavioral symptoms and attentional learning. J Am Acad Child Adolesc Psychiatry (1993) 0.89
Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Curr Genomics (2011) 0.89
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder. J Child Adolesc Psychopharmacol (2006) 0.88
Array comparative genomic hybridization findings in a cohort referred for an autism evaluation. J Child Neurol (2010) 0.88
Risperidone-induced prolactin elevation in a prospective study of children, adolescents, and adults with mental retardation and pervasive developmental disorders. J Child Adolesc Psychopharmacol (2005) 0.86
Guanfacine and guanfacine extended release: treatment for ADHD and related disorders. CNS Drug Rev (2007) 0.86
Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials. Res Dev Disabil (2004) 0.85
Mitochondrial genes and disease. Hosp Pract (Off Ed) (1986) 0.85
Autistic regression and disintegrative disorder: how important the role of epilepsy? Semin Pediatr Neurol (1995) 0.84
RECENT DEVELOPMENTS IN NEUROPATHOLOGY OF AUTISM SPECTRUM DISORDERS. Transl Neurosci (2011) 0.84
Retrospective study of quetiapine in children and adolescents with pervasive developmental disorders. J Autism Dev Disord (2005) 0.84
Quetiapine in nine youths with autistic disorder. J Child Adolesc Psychopharmacol (2004) 0.83
Placebo-controlled acute dosage naltrexone study in young autistic children. Psychiatry Res (1995) 0.82
Naltrexone in autistic children: a double-blind and placebo-controlled study. Psychopharmacol Bull (1990) 0.81
A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism. J Clin Psychiatry (1992) 0.81
The biological basis of autism. Curr Opin Neurobiol (1997) 0.78
Naltrexone and communication skills in young children with autism. J Am Acad Child Adolesc Psychiatry (1999) 0.77
When is polypharmacy an advantage? Am J Psychiatry (2011) 0.77
Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. J Clin Psychopharmacol (2006) 0.76
Attention deficit hyperactivity disorder, chronic tic disorder, and methylphenidate. Adv Neurol (2006) 0.76
Long-Term Aripiprazole in Youth With Developmental Disabilities Including Autism. J Ment Health Res Intellect Disabil (2011) 0.76
Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors. J Neurosci (2007) 2.57
Cellular and molecular bases of the initiation of fever. PLoS Biol (2006) 1.98
Microdeletion/microduplication of proximal 15q11.2 between BP1 and BP2: a susceptibility region for neurological dysfunction including developmental and language delay. Hum Genet (2011) 1.94
Nicotine administration and withdrawal affect survival in systemic inflammation models. J Appl Physiol (1985) (2008) 1.48
ANKRD11 gene deletion in a 17-year-old male. Clin Dysmorphol (2011) 1.09
Cyclooxygenase-1 or -2--which one mediates lipopolysaccharide-induced hypothermia? Am J Physiol Regul Integr Comp Physiol (2009) 0.98
A clinical report and further delineation of the 14q32 deletion syndrome. Clin Dysmorphol (2011) 0.95
Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Curr Genomics (2011) 0.89
IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features. Eur J Med Genet (2011) 0.85
Structural Chromosome Abnormalities Associated with Obesity: Report of Four New subjects and Review of Literature. Curr Genomics (2011) 0.84
An 18-year follow-up report on an infant with a duplication of 9q34. Am J Med Genet A (2010) 0.83
Use of functional analysis methodology in the evaluation of medication effects. J Autism Dev Disord (2003) 0.83
Effects of risperidone on destructive behavior of persons with developmental disabilities: III. Functional analysis. Am J Ment Retard (2004) 0.81
12-year-old boy with a 4q35.2 microdeletion and involvement of MTNR1A, FAT1, and F11 genes. Clin Dysmorphol (2012) 0.79
Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions. Exp Clin Psychopharmacol (2002) 0.76
Much improved outcome with gabapentin-divalproex combination in adults with bipolar disorders and developmental disabilities. J Clin Psychopharmacol (2006) 0.76
Use of and occupational exposure to indium in the United States. J Occup Environ Hyg (2013) 0.75
14q32 deletion syndrome: a clinical report. Clin Dysmorphol (2012) 0.75
Ocular and respiratory symptoms among lifeguards at a hotel indoor waterpark resort. J Occup Environ Med (2010) 0.75
Training of child and adolescent psychiatry fellows in autism and intellectual disability. Autism (2013) 0.75
Efficacy and safety of selective serotonin reuptake inhibitors in the treatment of depression in children and adolescents: practitioner review. Clin Drug Investig (2006) 0.75
A retrospective study of amitriptyline in youth with autism spectrum disorders. J Autism Dev Disord (2013) 0.75